Medication info
Humethin Tablets (Cimetidine)

Humethin Tablets (Cimetidine)

Prescription medicationTabletOral
Ingredient · strength
Cimetidine›200mg / 1 tablet
Manufacturer / importer
Huvist Pharmaceutical Co., Ltd.
Appearance
Light green to green round film-coated tablet
Packaging
30 tablets/bottle, 1000 tablets/bottle
Approval status
Active

MFDS item code 201403734 · Approved 2014.08.12 · Insurance code 628800070

Summary

Main use
Gastric acid disorders (ulcers, gastroesophageal reflux disease, Zollinger-Ellison syndrome, etc.); improvement of gastric mucosal lesions in gastritis
Who takes it
Adults · Children
Adult dose
Adults: Administer cimetidine orally as 400 mg twice daily (morning and at bedtime), or 800 mg once daily (at bedtime). Alternatively, administer 300 mg four times daily (after meals and at bedtime). The dose may be increased to 400 mg four times daily (after meals and at bedtime) (a total of 1.6 g). However, for improvement of gastric mucosal lesions (erosion, bleeding, redness, and edema) in acute gastritis or acute exacerbation of chronic gastritis, administer 200 mg twice daily or 400 mg once daily. An antacid may be administered as needed for pain relief. The dose may be increased in some patients; in such cases, increase the frequency of administration rather than the amount per dose. Do not exceed 2.4 g daily. Patients with renal impairment: Administer 300 mg of this medicine twice daily, 12 hours apart. If necessary, depending on the patient's symptoms, the frequency may be increased to three times daily, every 8 hours, or more, but use caution. Since the medicine may accumulate in the body in patients with severe renal impairment, minimize the frequency of administration according to the patient's response. Hemodialysis lowers the blood cimetidine level. After hemodialysis is completed, administer the medicine again according to the schedule. Adjust the dose appropriately according to age and symptoms.
Child dose
Administer 20 〜 40 mg per kg of body weight daily in divided oral doses.

Ingredients

Manufacturer
Huvist Pharmaceutical Co., Ltd.

Efficacy & effects

Gastric acid disorders (ulcers, gastroesophageal reflux disease, Zollinger-Ellison syndrome, etc.); improvement of gastric mucosal lesions in gastritis

  • Gastric ulcers
  • duodenal ulcers
  • gastroesophageal reflux disease
  • recurrent ulcers
  • anastomotic ulcers
  • Zollinger-Ellison syndrome
  • gastric mucosal lesions
  • erosions
  • bleeding
  • redness
  • edema
  • acute gastritis
View approved original text

This medication is effective for various gastrointestinal disorders such as gastric and duodenal ulcers, gastroesophageal reflux disease, recurrent ulcers, anastomotic ulcers, and Zollinger-Ellison syndrome. It also helps improve gastric mucosal lesions like erosions, bleeding, redness, and edema that occur during acute exacerbations of acute and chronic gastritis. By alleviating the symptoms of various gastrointestinal disorders and promoting healing, it enhances digestive health for patients.

How to take

Adult dose

Adults: Administer cimetidine orally as 400 mg twice daily (morning and at bedtime), or 800 mg once daily (at bedtime). Alternatively, administer 300 mg four times daily (after meals and at bedtime). The dose may be increased to 400 mg four times daily (after meals and at bedtime) (a total of 1.6 g). However, for improvement of gastric mucosal lesions (erosion, bleeding, redness, and edema) in acute gastritis or acute exacerbation of chronic gastritis, administer 200 mg twice daily or 400 mg once daily. An antacid may be administered as needed for pain relief. The dose may be increased in some patients; in such cases, increase the frequency of administration rather than the amount per dose. Do not exceed 2.4 g daily. Patients with renal impairment: Administer 300 mg of this medicine twice daily, 12 hours apart. If necessary, depending on the patient's symptoms, the frequency may be increased to three times daily, every 8 hours, or more, but use caution. Since the medicine may accumulate in the body in patients with severe renal impairment, minimize the frequency of administration according to the patient's response. Hemodialysis lowers the blood cimetidine level. After hemodialysis is completed, administer the medicine again according to the schedule. Adjust the dose appropriately according to age and symptoms.

Child dose

Administer 20 〜 40 mg per kg of body weight daily in divided oral doses.

Precautions

This medication contains cimetidine and should not be administered to certain patients. Firstly, it should not be used in patients who have had allergic reactions to this medication or cimetidine. Also, patients taking dofetilide are at increased risk of cardiac arrhythmia, so it is not administered. This medication contains lactose, so it should not be given to patients with lactose intolerance or certain genetic sugar absorption disorders. Patients with impaired renal or liver function, history of drug allergies, elderly patients, children under 19 years of age, and patients undergoing hemodialysis should use it cautiously. Especially in patients with renal impairment, drug concentration in the blood may increase, requiring dosage adjustment or alteration of the dosing interval. This medication may mask symptoms of gastric cancer, so it should only be administered after ruling out malignancy. Patients with gastric ulcers infected with Helicobacter pylori should receive treatment to eradicate the bacteria. This medication may have multiple side effects, and if fatigue, bleeding, or fever occurs due to a decrease in blood cell counts, the medication should be stopped immediately and blood tests performed. There is also a rare risk of liver dysfunction, jaundice, and symptoms of hepatitis, so caution is warranted. If symptoms of renal impairment or abnormalities in blood tests occur, the medication should be stopped immediately. Allergic reactions may present as shock, respiratory distress, or skin rashes, and if these symptoms occur, administration should be halted. Endocrine side effects such as gynecomastia, excessive milk secretion, and erectile dysfunction have also been reported. Gastrointestinal symptoms such as abdominal bloating, constipation, and diarrhea may occur. Neurological symptoms such as headache, dizziness, seizures, drowsiness, and confusion may manifest, so if any abnormal signs occur, consulting a physician immediately is advised. Abnormal heart rhythms or severe skin rashes, or skin exfoliation have been reported rarely as well, so caution is necessary. Patients may also experience fatigue, fever, urinary difficulties, muscle pain, and hair loss while taking this medication. Additionally, this medication can interact with many other medications, so particularly with anticoagulants, anxiolytics, and cardiac drugs, a consultation with a physician is essential. Women who are pregnant or may become pregnant should use this medication cautiously only when necessary, as its safety has not been established, and breastfeeding mothers should discontinue breastfeeding when taking this medication. In children or elderly patients, dosage adjustments and monitoring are required due to the increased risk of elevated drug concentration due to diminished renal function. In cases of overdose, serious symptoms such as respiratory depression may occur, and immediate emergency treatment is required. This medication should be stored out of reach of children and not transferred to other containers for safety. If there is no therapeutic effect or severe side effects, the medication should be discontinued and a physician consulted to consider alternative treatments.

Side effects

  • Leukopenia
  • granulocytopenia
  • agranulocytosis
  • thrombocytopenia
  • pancytopenia
  • aplastic anemia
  • immune hemolytic anemia
  • jaundice
  • hepatitis
  • elevated AST
Show 48 more
  • elevated ALT
  • hepatic fibrosis
  • interstitial seizures
  • acute renal failure
  • interstitial nephritis
  • urinary retention
  • elevated BUN
  • elevated serum creatinine
  • shock
  • anaphylaxis-like reaction
  • hypersensitivity vasculitis
  • rash
  • gynecomastia
  • hyperlactation
  • increased leukorrhea
  • erectile dysfunction
  • abdominal bloating
  • constipation
  • diarrhea
  • headache
  • dizziness
  • seizures
  • limb numbness
  • stiffness
  • drowsiness
  • hypochondriacal symptoms
  • weakness
  • consciousness disturbance
  • confusional state
  • bradycardia
  • tachycardia
  • palpitations
  • heart block
  • skin and mucous membrane syndrome
  • toxic epidermal necrolysis
  • epidermal necrosis
  • erythema multiforme
  • exfoliative dermatitis
  • generalized exfoliative erythema
  • fatigue
  • fever
  • systemic heat sensation
  • dysuria
  • myalgia
  • arthralgia
  • pancreatitis
  • hair loss
  • polymyositis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a closed container that blocks light and at a temperature between 1 to 30 degrees Celsius. This storage helps maintain effectiveness and prevent degradation.

Appearance and packaging

Appearance

Light green to green round film-coated tablet

Package unit

30 tablets/bottle, 1000 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.